Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Vitamin E inhibits CD95 ligand expression and protects T cells from activation-induced cell death
Min Li-Weber, … , Raoul Breitkreutz, Peter H. Krammer
Min Li-Weber, … , Raoul Breitkreutz, Peter H. Krammer
Published September 1, 2002
Citation Information: J Clin Invest. 2002;110(5):681-690. https://doi.org/10.1172/JCI15073.
View: Text | PDF
Article Genetics

Vitamin E inhibits CD95 ligand expression and protects T cells from activation-induced cell death

  • Text
  • PDF
Abstract

Research Article

Authors

Min Li-Weber, Markus A. Weigand, Marco Giaisi, Dorothee Süss, Monika K. Treiber, Sven Baumann, Elena Ritsou, Raoul Breitkreutz, Peter H. Krammer

×

Figure 7

Options: View larger image (or click on image) Download as PowerPoint
Effect of vitamin E on AICD of peripheral blood lymphocytes of HIV-posit...
Effect of vitamin E on AICD of peripheral blood lymphocytes of HIV-positive individuals. (a) AICD is increased in HIV-infected individuals. Peripheral blood T lymphocytes from 33 HIV-positive individuals and 11 uninfected donors were stimulated with plate-bound α-CD3 for 48 hours. Apoptosis was assessed by FSC/SSC analysis. The mean difference between patients and uninfected individuals is –7.23. The 95% confidence interval is –13.7 to –2.12. (b and c) Vitamin E prevents AICD of T lymphocytes of HIV-positive individuals. Freshly isolated blood T lymphocytes from 31 HIV-positive individuals were individually stimulated with plate-bound α-CD3 in the absence (x axis) or presence (y axis) of either CD95Fc (b, 27 patients) or vitamin E (c, 24 patients) as indicated. IgG1 was used as control. Cell death was assessed after 48 hours’ stimulation and subjected to statistical analysis. (d) Comparison of CD95Fc- and vitamin E–mediated inhibition of α-CD3–induced specific cell death of HIV-positive individuals. AICD from 22 of 31 HIV-positive individuals tested was downregulated in the presence of either CD95Fc or vitamin E. Results are presented as percent inhibition of α-CD3–induced specific cell death by CD95Fc or by vitamin E.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts